Dự đoán phản ứng của ung thư biểu mô gan tế bào đối với liệu pháp tắc mạch hóa trị bằng hình ảnh khuếch tán không đồng nhất intra voxel
Tóm tắt
Từ khóa
Tài liệu tham khảo
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249
Chen Q, Cheng C, Chen H, Ning Z, Tang S, Zhang X et al (2014) Effectiveness and complications of ultrasound guided fine needle aspiration for primary liver cancer in a Chinese population with serum α-fetoprotein levels ≤ 200 ng/ml-a study based on 4,312 patients. PLoS ONE 9(8):e101536
Raoul J-L, Forner A, Bolondi L, Cheung TT, Kloeckner R, de Baere T (2019) Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence. Cancer Treat Rev 72:28–36
Sapisochin G, Barry A, Doherty M, Fischer S, Goldaracena N, Rosales R et al (2017) Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis. J Hepatol 67(1):92–99
Sieghart W, Hucke F, Peck-Radosavljevic M (2015) Transarterial chemoembolization: modalities, indication, and patient selection. J Hepatol 62(5):1187–1195
Poon RT-P, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Annals of surgery. 2002;235(3):373.
Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S (2015) Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg 261(5):947–955
Tsilimigras DI, Bagante F, Sahara K, Moris D, Hyer JM, Wu L et al (2019) Prognosis after resection of Barcelona Clinic Liver Cancer (BCLC) stage 0, A, and B hepatocellular carcinoma: a comprehensive assessment of the current BCLC classification. Ann Surg Oncol 26(11):3693–3700
Pinato DJ, Howell J, Ramaswami R, Sharma R (2017) delivering precision oncology in intermediate-stage liver cancer. Aliment Pharmacol Ther 45(12):1514–1523
An C, Kim DW, Park Y-N, Chung YE, Rhee H, Kim M-J (2015) Single hepatocellular carcinoma: preoperative MR imaging to predict early recurrence after curative resection. Radiology 276(2):433–443
Jia F, Wu B, Yan R, Li L, Wang K, Han D (2020) Prediction model for intermediate-stage hepatocellular carcinoma response to transarterial chemoembolization. J Magn Reson Imaging 52(6):1657–1667
Hsu C-Y, Shen Y-C, Yu C-W, Hsu C, Hu F-C, Hsu C-H et al (2011) Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil. J Hepatol 55(4):858–865
Niu J, Li W, Wang H, Wu W, Gong T, Huang N et al (2017) Intravoxel incoherent motion diffusion-weighted imaging of bone marrow in patients with acute myeloid leukemia: a pilot study of prognostic value. J Magn Reson Imaging 46(2):476–482
Zhu L, Wang H, Zhu L, Meng J, Xu Y, Liu B et al (2017) Predictive and prognostic value of intravoxel incoherent motion (IVIM) MR imaging in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy. Sci Rep 7(1):1–9
Messina C, Bignone R, Bruno A, Bruno A, Bruno F, Calandri M et al (2020) Diffusion-weighted imaging in oncology: an update. Cancers 12(6):1493
Koh D-M, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. Am J Roentgenol 188(6):1622–1635
Barral M, Taouli B, Guiu B, Koh D-M, Luciani A, Manfredi R et al (2015) Diffusion-weighted MR imaging of the pancreas: current status and recommendations. Radiology 274(1):45–63
Le Bihan D, Breton E, Lallemand D, Aubin M, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168(2):497–505
Lencioni R, Llovet JM, editors. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Seminars in liver disease; 2010: © Thieme Medical Publishers.
Zhang Y, Kuang S, Shan Q, Rong D, Zhang Z, Yang H et al (2019) Can IVIM help predict HCC recurrence after hepatectomy? Eur Radiol 29(11):5791–5803
Kakite S, Dyvorne HA, Lee KM, Jajamovich GH, Knight-Greenfield A, Taouli B (2016) Hepatocellular carcinoma: IVIM diffusion quantification for prediction of tumor necrosis compared to enhancement ratios. Eur J Radiol Open 3:1–7
Park YS, Lee CH, Kim JH, Kim IS, Kiefer B, Seo TS et al (2014) Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result. Magn Reson Imaging 32(6):638–646
Ludwig JM, Camacho JC, Kokabi N, Xing M, Kim HS (2015) The role of diffusion-weighted imaging (DWI) in locoregional therapy outcome prediction and response assessment for hepatocellular carcinoma (HCC): the new era of functional imaging biomarkers. Diagnostics 5(4):546–563
Kokabi N, Ludwig JM, Camacho JC, Xing M, Mittal PK, Kim HS (2015) Baseline and early MR apparent diffusion coefficient quantification as a predictor of response of unresectable hepatocellular carcinoma to doxorubicin drug-eluting bead chemoembolization. J Vasc Interv Radiol 26(12):1777–1786